20434-92-8 Usage
Uses
Used in Pharmaceutical Applications:
2-(4-Hydroxyphenyl)-2H-isoquinolin-1-one is used as a therapeutic agent for various conditions, including diabetes and high cholesterol, due to its ability to regulate glucose and lipid metabolism. It also exhibits antimicrobial properties, making it effective against gastrointestinal infections caused by certain pathogens.
Used in Anticancer Applications:
In the field of oncology, 2-(4-Hydroxyphenyl)-2H-isoquinolin-1-one is employed as an anticancer agent, showing potential in the treatment of specific types of cancer. Its mechanism of action involves the modulation of cellular signaling pathways and the induction of apoptosis in cancer cells, thereby inhibiting tumor growth and progression.
Used in Traditional Medicine:
Berberine has been a staple in traditional medicine for centuries, utilized for its anti-inflammatory and antioxidative properties. It is used to alleviate inflammation and oxidative stress-related conditions, promoting overall health and well-being.
Used in Food and Beverage Industry:
2-(4-Hydroxyphenyl)-2H-isoquinolin-1-one is used as a natural dye and flavoring agent in the food and beverage industry. Its vibrant yellow color and unique flavor profile contribute to the aesthetic appeal and taste of various products.
Used in Cosmetics Industry:
In the cosmetics industry, berberine is used for its potential skin health benefits, such as its anti-inflammatory and antioxidative properties. It can be incorporated into skincare products to promote a healthy and radiant complexion.
Check Digit Verification of cas no
The CAS Registry Mumber 20434-92-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,4,3 and 4 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 20434-92:
(7*2)+(6*0)+(5*4)+(4*3)+(3*4)+(2*9)+(1*2)=78
78 % 10 = 8
So 20434-92-8 is a valid CAS Registry Number.
InChI:InChI=1/C15H11NO2/c17-12-7-5-10(6-8-12)14-9-11-3-1-2-4-13(11)15(18)16-14/h1-9,17H,(H,16,18)
20434-92-8Relevant academic research and scientific papers
TREATMENT OF DISEASES BY EPIGENETIC REGULATION
-
, (2013/11/05)
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of cancer, including NUT midline carcinoma, Burkitt's Lymphoma, Acute Myelogenous Leukemia, and Multiple Myeloma; autoimmune or inflammatory diseases or conditions, and sepsis.
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
-
Page/Page column 22, (2008/12/07)
The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF COMPLEX DISEASES AND THEIR DELIVERY BY INSERTABLE MEDICAL DEVICES
-
Page/Page column 68-69, (2008/06/13)
The present invention relates to polyphenol-like compounds that are useful for inhibiting VCAM-1 expression, MCP-1 expression and/or SMC proliferation in a mammal. The disclosed compounds are useful for regulating markers of inflammatory conditions, including vascular inflammation, and for treatment and prevention of inflammatory and cardiovascular diseases and related disease states.
